Report cover image

Europe Dengue Treatment Market

Publisher Data Bridge Market Research
Published Jun 01, 2024
Length 226 Pages
SKU # DAABD19026873

Description

Europe Dengue Treatment Market


Europe dengue treatment market is expected to reach 174.28 million by 2031, from USD 83.46 million in 2023, growing at the CAGR of 9.6% in the forecast period of 2024 to 2031.

Market Segmentation:
Europe Dengue Treatment Market, By Strains (DENV-2, DENV-3, DENV-1, DENV-4, and Others), Type (Vaccines and Acetaminophen), Severity (Mild to Moderate Dengue and Severe Dengue), Route of Administration (Parenteral and Oral), Mode of Purchase (Prescription and Over-the-Counter (OTC)), Gender (Male and Female), Age (Adult, Pediatric, and Geriatric), End User (Hospital, Specialty Clinics, Home Healthcare, and Others), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies), By Countries (Germany, U.K., Italy, France, Spain, Russia, Switzerland, Turkey, Belgium, Netherlands, and Rest of Europe) - Industry Trends and Forecast to 2031

Overview of Europe Dengue Treatment Market Dynamics:
Driver

• Rising dengue incidence rate result in the demand for effective treatment
Restrain

• Delay in the approval process of vaccines

Opportunity

• Growing number of pipeline vaccines for dengue treatment

Market Players:
The key market players operating in the Europe dengue treatment market are listed below:
• Sanofi
• Takeda Pharmaceutical Company Limited
• Viatris Inc.
• Johnson & Johnson
• GSK plc.
• Perrigo Company PLC
• Baxter
• Fresenius Kabi USA
• Pfizer
• Hikma Pharmaceuticals PLC
• Sun Pharmaceutical Industries Ltd
• Teva Pharmaceuticals USA, Inc.
• Aurobindo Pharma

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

226 Pages
1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Dengue Treatment Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Market Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Market Application Coverage Grid
2.8 Product Lifeline Curve
2.9 Dbmr Market Position Grid
2.10 Vendor Share Analysis
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
4.1 Pestel Analysis
4.2 Porter’s Five Forces
5 Europe Dengue Treatment Market: Regulations
5.1 U.S. Regulatory Scenario For Dengue Treatment
5.2 Europe Regulatory Scenario For Dengue Treatment
5.3 Developing Countries Regulatory Framework
5.4 Legislation For Control Of Dengue In Singapore
5.5 Dvcrn Developing Vaccine Regulators Network
6 Market Overview
6.1 Drivers
6.1.1 Rising Dengue Incidence Rate Result In The Demand For Effective Treatment
6.1.2 Rising Wave Of Dengue Vaccine Launches
6.1.3 Government Initiatives And Vaccination Programs
6.1.4 Growth Of Medical Insurance In Emerging Countries
6.2 Restraints
6.2.1 Delay In The Approval Process Of Vaccines
6.2.2 Lack Of Awareness And Healthcare Infrastructure For Treatment Of Dengue
6.2.3 Difficulty In The Detection Assay For Dengue
6.3 Opportunities
6.3.1 Strategic Collaboration Within The Pharmaceutical Industry Fuels The Market
6.3.2 Growing Number Of Pipeline Vaccines For Dengue Treatment
6.3.3 Rising R&D Investment And Activities
6.4 Challenges
6.4.1 Healthcare Services Are Limitedly Accessible In Rural Areas
6.4.2 High Costs Of Treatment Restrict The Feasibility Of Cost-effective Solutions
7 Europe Dengue Treatment Market, By Strains
7.1 Overview
7.2 Denv-2
7.3 Denv-3
7.4 Denv-1
7.5 Denv-4
7.6 Others
8 Europe Dengue Treatment Market, By Type
8.1 Overview
8.2 Vaccines
8.2.1 Dengvaxia (Cyd-tdv)
8.2.2 Qdenga
8.3 Acetaminophen
8.3.1 Parenteral
8.3.2 Oral
8.3.3 Other
9 Europe Dengue Treatment Market, By Severity
9.1 Overview
9.2 Mild To Moderate Dengue
9.3 Severe Dengue
10 Europe Dengue Treatment Market, By Route Of Administration
10.1 Overview
10.2 Parenteral
10.2.1 Sub-cutaneous
10.2.2 Intravenous
10.3 Oral
10.3.1 Tablet
10.3.2 Capsules
10.3.3 Others
11 Europe Dengue Treatment Market, By Mode Of Purchase
11.1 Overview
11.2 Prescription
11.3 Over-the-counter (Otc)
12 Europe Dengue Treatment Market, By Gender
12.1 Overview
12.2 Male
12.3 Female
13 Europe Dengue Treatment Market, By Age
13.1 Overview
13.2 Adult
13.3 Pediatric
13.4 Geriatric
14 Europe Dengue Treatment Market, By End User
14.1 Overview
14.2 Hospital
14.3 Specialty Clinics
14.4 Home Healthcare
14.5 Others
15 Europe Dengue Treatment Market, By Distribution Channel
15.1 Overview
15.2 Retail Pharmacies
15.3 Hospital Pharmacies
15.4 Online Pharmacies
16 Europe Dengue Treatment Market, By Region
16.1 Europe
16.1.1 France
16.1.2 Germany
16.1.3 Spain
16.1.4 U.K.
16.1.5 Belgium
16.1.6 Italy
16.1.7 Netherlands
16.1.8 Russia
16.1.9 Switzerland
16.1.10 Turkey
16.1.11 Rest Of Europe
17 Europe Dengue Treatment Market: Company Landscape
17.1 Company Share Analysis: Europe
18 Swot Analysis
19 Company Profile
19.1 Sanofi
19.1.1 Company Snapshot
19.1.2 Revenue Analysis
19.1.3 Company Share Analysis
19.1.4 Product Portfolio
19.1.5 Recent Developments
19.2 Takeda Pharmaceutical Company Limited
19.2.1 Company Snapshot
19.2.2 Revenue Analysis
19.2.3 Company Share Analysis
19.2.4 Product Portfolio
19.2.5 Recent Developments
19.3 Viatris Inc.
19.3.1 Company Snapshot
19.3.2 Revenue Analysis
19.3.3 Company Share Analysis
19.3.4 Product Portfolio
19.3.5 Recent Developments
19.4 Johnson & Johnson Services, Inc.
19.4.1 Company Snapshot
19.4.2 Revenue Analysis
19.4.3 Company Share Analysis
19.4.4 Product Portfolio
19.4.5 Recent Development
19.5 Gsk Plc.
19.5.1 Company Snapshot
19.5.2 Revenue Analysis
19.5.3 Company Share Analysis
19.5.4 Product Portfolio
19.5.5 Recent Developments
19.6 Aurobindo Pharma
19.6.1 Company Snapshot
19.6.2 Revenue Analysis
19.6.3 Product Portfolio
19.7 Baxter
19.7.1 Company Snapshot
19.7.2 Revenue Analysis
19.7.3 Product Portfolio
19.8 Fresenius Kabi Usa
19.8.1 Company Snapshot
19.8.2 Product Portfolio
19.8.3 Recent Developments
19.9 Hikma Pharmaceuticals
19.9.1 Company Snapshot
19.9.2 Revenue Analysis
19.9.3 Product Portfolio
19.9.4 Recent Development
19.10 Perrigo Company Plc
19.10.1 Company Snapshot
19.10.2 Revenue Analysis
19.10.3 Product Portfolio
19.10.4 Recent Development
19.11 Pfizer Inc.
19.11.1 Company Snapshot
19.11.2 Revenue Analysis
19.11.3 Product Portfolio
19.11.4 Recent Developments
19.12 Sun Pharmaceutical Industries Ltd
19.12.1 Company Snapshot
19.12.2 Revenue Analysis
19.12.3 Product Portfolio
19.12.4 Recent Development
19.13 Teva Pharmaceuticals Usa, Inc.
19.13.1 Company Snapshot
19.13.2 Revenue Analysis
19.13.3 Product Portfolio
19.13.4 Recent Development
20 Questionnaire
21 Related Reports
Table 1 Three Phases For Health Protection Outlined By The European World Health Organization
Table 2 Impact Of Delay In Approval Process
Table 3 Europe Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 4 Europe Denv-2 In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 5 Europe Denv-3 In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 6 Europe Denv-1 In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 7 Europe Denv-4 In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 8 Europe Others In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 9 Europe Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 10 Europe Vaccines In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 11 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 12 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 13 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 14 Europe Acetaminophen In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 15 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 16 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 17 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 18 Europe Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 19 Europe Mild To Moderate Dengue In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 20 Europe Severe Dengue In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 21 Europe Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 22 Europe Parenteral In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 23 Europe Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 24 Europe Oral In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 25 Europe Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 26 Europe Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 27 Europe Prescription In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 28 Europe Over-the-counter (Otc) In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 29 Europe Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 30 Europe Male In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 31 Europe Female In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 32 Europe Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 33 Europe Adult In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 34 Europe Pediatric In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 35 Europe Geriatric In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 36 Europe Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 37 Europe Hospital In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 38 Europe Speciality Clinics In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 39 Europe Home Healthcare In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 40 Europe Others In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 41 Europe Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 42 Europe Retail Pharmacies In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 43 Europe Hospital Pharmacies In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 44 Europe Online Pharmacies In Dengue Treatment Market, By Region, 2022-2031 (Usd Million)
Table 45 Europe Dengue Treatment Market, By Country, 2022-2031 (Usd Million)
Table 46 Europe Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 47 Europe Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 48 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 49 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 50 Europe Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 51 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 52 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 53 Europe Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 54 Europe Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 55 Europe Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 56 Europe Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 57 Europe Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 58 Europe Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 59 Europe Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 60 Europe Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 61 Europe Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 62 Europe Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 63 France Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 64 France Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 65 France Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 66 France Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 67 France Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 68 France Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 69 France Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 70 France Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 71 France Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 72 France Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 73 France Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 74 France Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 75 France Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 76 France Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 77 France Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 78 France Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 79 France Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 80 Germany Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 81 Germany Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 82 Germany Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 83 Germany Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 84 Germany Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 85 Germany Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 86 Germany Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 87 Germany Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 88 Germany Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 89 Germany Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 90 Germany Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 91 Germany Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 92 Germany Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 93 Germany Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 94 Germany Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 95 Germany Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 96 Germany Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 97 Spain Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 98 Spain Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 99 Spain Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 100 Spain Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 101 Spain Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 102 Spain Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 103 Spain Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 104 Spain Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 105 Spain Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 106 Spain Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 107 Spain Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 108 Spain Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 109 Spain Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 110 Spain Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 111 Spain Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 112 Spain Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 113 Spain Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 114 U.K. Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 115 U.K. Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 116 U.K. Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 117 U.K. Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 118 U.K. Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 119 U.K. Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 120 U.K. Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 121 U.K. Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 122 U.K. Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 123 U.K. Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 124 U.K. Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 125 U.K. Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 126 U.K. Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 127 U.K. Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 128 U.K. Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 129 U.K. Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 130 U.K. Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 131 Belgium Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 132 Belgium Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 133 Belgium Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 134 Belgium Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 135 Belgium Vaccines In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 136 Belgium Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 137 Belgium Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Volume)
Table 138 Belgium Acetaminophen In Dengue Treatment Market, By Type, 2022-2031 (Asp)
Table 139 Belgium Dengue Treatment Market, By Severity, 2022-2031 (Usd Million)
Table 140 Belgium Dengue Treatment Market, By Route Of Administration, 2022-2031 (Usd Million)
Table 141 Belgium Parenteral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 142 Belgium Oral In Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Table 143 Belgium Dengue Treatment Market, By Mode Of Purchase, 2022-2031 (Usd Million)
Table 144 Belgium Dengue Treatment Market, By Gender, 2022-2031 (Usd Million)
Table 145 Belgium Dengue Treatment Market, By Age, 2022-2031 (Usd Million)
Table 146 Belgium Dengue Treatment Market, By End User, 2022-2031 (Usd Million)
Table 147 Belgium Dengue Treatment Market, By Distribution Channel, 2022-2031 (Usd Million)
Table 148 Italy Dengue Treatment Market, By Strains, 2022-2031 (Usd Million)
Table 149 Italy Dengue Treatment Market, By Type, 2022-2031 (Usd Million)
Figure 1 Europe Dengue Treatment Market: Segmentation
Figure 2 Europe Dengue Treatment Market: Data Triangulation
Figure 3 Europe Dengue Treatment Market: Droc Analysis
Figure 4 Europe Dengue Treatment Market: Europe Vs Regional Market Analysis
Figure 5 Europe Dengue Treatment Market: Company Research Analysis
Figure 6 Europe Dengue Treatment Market: Interview Demographics
Figure 7 Europe Dengue Treatment Market: Market Application Coverage Grid
Figure 8 Europe Dengue Treatment Market: Dbmr Market Position Grid
Figure 9 Europe Dengue Treatment Market: Vendor Share Analysis
Figure 10 Europe Dengue Treatment Market: Segmentation
Figure 11 Growing Pharmaceutical Industry Is Driving The Growth Of The Europe Dengue Treatment Market From 2024 To 2031
Figure 12 On The Basis Of Strains, The Denv-2 Segment Is Expected To Account For The Largest Share Of The Europe Dengue Treatment Market In 2024 And 2031
Figure 13 Drivers, Restraints, Opportunities, And Challenges Of Europe Dengue Treatment Market
Figure 14 Financial Budget For Vector-borne -diseases Including Dengue In India
Figure 15 Europe Dengue Treatment Market: By Strains, 2023
Figure 16 Europe Dengue Treatment Market: By Strains, 2024-2031 (Usd Million)
Figure 17 Europe Dengue Treatment Market: By Strains, Cagr (2024-2031)
Figure 18 Europe Dengue Treatment Market: By Strains, Lifeline Curve
Figure 19 Europe Dengue Treatment Market: By Type, 2023
Figure 20 Europe Dengue Treatment Market: By Type, 2024-2031 (Usd Million)
Figure 21 Europe Dengue Treatment Market: By Type, Cagr (2024-2031)
Figure 22 Europe Dengue Treatment Market: By Type, Lifeline Curve
Figure 23 Europe Dengue Treatment Market: By Severity, 2023
Figure 24 Europe Dengue Treatment Market: By Severity, 2024-2031 (Usd Million)
Figure 25 Europe Dengue Treatment Market: By Severity, Cagr (2024-2031)
Figure 26 Europe Dengue Treatment Market: By Severity, Lifeline Curve
Figure 27 Europe Dengue Treatment Market: By Route Of Administration, 2023
Figure 28 Europe Dengue Treatment Market: By Route Of Administration, 2024-2031 (Usd Million)
Figure 29 Europe Dengue Treatment Market: By Route Of Administration, Cagr (2024-2031)
Figure 30 Europe Dengue Treatment Market: By Route Of Administration, Lifeline Curve
Figure 31 Europe Dengue Treatment Market: By Mode Of Purchase, 2023
Figure 32 Europe Dengue Treatment Market: By Mode Of Purchase, 2024-2031 (Usd Million)
Figure 33 Europe Dengue Treatment Market: By Mode Of Purchase, Cagr (2024-2031)
Figure 34 Europe Dengue Treatment Market: By Mode Of Purchase, Lifeline Curve
Figure 35 Europe Dengue Treatment Market: By Gender, 2023
Figure 36 Europe Dengue Treatment Market: By Gender, 2024-2031 (Usd Million)
Figure 37 Europe Dengue Treatment Market: By Gender, Cagr (2024-2031)
Figure 38 Europe Dengue Treatment Market: By Gender, Lifeline Curve
Figure 39 Europe Dengue Treatment Market: By Age, 2023
Figure 40 Europe Dengue Treatment Market: By Age, 2024-2031 (Usd Million)
Figure 41 Europe Dengue Treatment Market: By Age, Cagr (2024-2031)
Figure 42 Europe Dengue Treatment Market: By Age, Lifeline Curve
Figure 43 Europe Dengue Treatment Market: By End User, 2023
Figure 44 Europe Dengue Treatment Market: By End User, 2024-2031 (Usd Million)
Figure 45 Europe Dengue Treatment Market: By End User, Cagr (2024-2031)
Figure 46 Europe Dengue Treatment Market: By End User, Lifeline Curve
Figure 47 Europe Dengue Treatment Market: By Distribution Channel, 2023
Figure 48 Europe Dengue Treatment Market: By Distribution Channel, 2024-2031 (Usd Million)
Figure 49 Europe Dengue Treatment Market: By Distribution Channel, Cagr (2024-2031)
Figure 50 Europe Dengue Treatment Market: By Distribution Channel, Lifeline Curve
Figure 51 Europe Dengue Treatment Market: Snapshot (2023)
Figure 52 Europe Dengue Treatment Market: Company Share 2022 (%)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us